Latest news
CEO Johan Wäborg at Redeye Investor Forum
At April 10 Johan Wäborg, CEO at Iconovo presented the company at Redeye Investor Forum in Gothenburg, Sweden.
Iconovo: CEO Johan Wäborg presents…
CEO Johan Wäborg: how do we take GLP-1’s in the future?
Why would you inject yourself… if you could just sniff it? No one likes needles. It becomes a big deal when you’re talking about the world’s most…
Press releases
Dec 21, 2020, 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Dec 21, 2020, 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Nov 26, 2020, 14:38
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 26, 2020, 14:38
News
IR
English
Corporate Information
Other Corporate Information
Nov 17, 2020, 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 17, 2020, 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Oct 28, 2020, 08:33
News
IR
English
Corporate Information
Other Corporate Information
Oct 27, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 19, 2020, 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 19, 2020, 13:30
News
IR
English
Corporate Information
Other Corporate Information
Sep 30, 2020, 09:00
News
IR
English
Corporate Information
Presentation
Sep 30, 2020, 09:00
News
IR
Swedish
Corporate Information
Presentation
Sep 15, 2020, 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 02, 2020, 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 20, 2020, 13:51
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2020, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2020, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 19, 2020, 09:30
News
IR
English
Corporate Information
Other Corporate Information
Aug 19, 2020, 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 19, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se